Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Sone
Akt Kinase-Interacting Protein1, a Novel Therapeutic Target for Lung Cancer With EGFR-activating and Gatekeeper Mutations
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations
OncoTargets and Therapy
Oncology
Pharmacology
EGFR Kinase Domain Mutations – Functional Impact and Relevance for Lung Cancer Therapy
Oncogene
Cancer Research
Genetics
Molecular Biology
DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Cancer Research
Cancer Research
Oncology
Cotargeting EGFR and Autophagy Signaling: A Novel Therapeutic Strategy for Non-Small-Cell Lung Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Allosterically Targeting EGFR Drug-Resistance Gatekeeper Mutations
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations
Cancer Discovery
Oncology
Influence of EGFR-activating Mutations on Sensitivity to Tyrosine Kinase Inhibitors in a KRAS Mutant Non-Small Cell Lung Cancer Cell Line
PLoS ONE
Multidisciplinary
OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients With EGFR Activating and T790M Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary